JP2024529533A5 - - Google Patents
Info
- Publication number
- JP2024529533A5 JP2024529533A5 JP2024506641A JP2024506641A JP2024529533A5 JP 2024529533 A5 JP2024529533 A5 JP 2024529533A5 JP 2024506641 A JP2024506641 A JP 2024506641A JP 2024506641 A JP2024506641 A JP 2024506641A JP 2024529533 A5 JP2024529533 A5 JP 2024529533A5
- Authority
- JP
- Japan
- Prior art keywords
- egfr
- degrees
- approximately
- xrpd pattern
- peaks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021110048 | 2021-08-02 | ||
| CNPCT/CN2021/110048 | 2021-08-02 | ||
| PCT/CN2022/109065 WO2023011358A1 (en) | 2021-08-02 | 2022-07-29 | Novel pharmaceutical salts and polymorphic forms of an erbb and btk inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529533A JP2024529533A (ja) | 2024-08-06 |
| JP2024529533A5 true JP2024529533A5 (https=) | 2025-08-06 |
Family
ID=85154265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506641A Pending JP2024529533A (ja) | 2021-08-02 | 2022-07-29 | Ｅｒｂｂおよびｂｔｋ阻害剤の新規な医薬塩および多形形態 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250197377A1 (https=) |
| EP (1) | EP4380924A4 (https=) |
| JP (1) | JP2024529533A (https=) |
| KR (1) | KR20240042640A (https=) |
| CN (1) | CN117794902A (https=) |
| AR (1) | AR126673A1 (https=) |
| AU (1) | AU2022324410A1 (https=) |
| CA (1) | CA3224748A1 (https=) |
| MX (1) | MX2024001367A (https=) |
| TW (1) | TW202321223A (https=) |
| WO (1) | WO2023011358A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4731307A1 (en) | 2023-06-23 | 2026-04-29 | Assia Chemical Industries Ltd. | Solid state forms of sunvozertinib |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014022790B1 (pt) * | 2012-03-15 | 2022-04-19 | Celgene Car Llc | Sais de um inibidor de quinase de receptor de fator do crescimento epidermal, composição farmacêutica e usos do mesmo |
| CN105384694B (zh) * | 2014-08-22 | 2020-09-04 | 四川海思科制药有限公司 | 一种取代的氨基嘧啶衍生物及其制备方法和药物用途 |
| CN106905245B (zh) * | 2015-12-23 | 2021-06-25 | 正大天晴药业集团股份有限公司 | 2,4-二取代的嘧啶类化合物 |
| CN106083736A (zh) * | 2016-06-21 | 2016-11-09 | 郑州泰基鸿诺医药股份有限公司 | 一种嘧啶类化合物、egfr抑制剂及其应用 |
| TWI798334B (zh) * | 2018-01-31 | 2023-04-11 | 大陸商迪哲（江蘇）醫藥股份有限公司 | Ｅｒｂｂ／ｂｔｋ抑制劑 |
| WO2019177375A1 (ko) * | 2018-03-13 | 2019-09-19 | 포로노이바이오 주식회사 | 2, 4, 5-치환된 피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물 |
-
2022
- 2022-07-29 CA CA3224748A patent/CA3224748A1/en active Pending
- 2022-07-29 KR KR1020247007187A patent/KR20240042640A/ko active Pending
- 2022-07-29 JP JP2024506641A patent/JP2024529533A/ja active Pending
- 2022-07-29 US US18/293,778 patent/US20250197377A1/en active Pending
- 2022-07-29 MX MX2024001367A patent/MX2024001367A/es unknown
- 2022-07-29 AU AU2022324410A patent/AU2022324410A1/en active Pending
- 2022-07-29 TW TW111128540A patent/TW202321223A/zh unknown
- 2022-07-29 CN CN202280053629.5A patent/CN117794902A/zh active Pending
- 2022-07-29 EP EP22852071.4A patent/EP4380924A4/en active Pending
- 2022-07-29 WO PCT/CN2022/109065 patent/WO2023011358A1/en not_active Ceased
- 2022-08-02 AR ARP220102058A patent/AR126673A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7660040B2 (ja) | ３－（（１Ｒ，３Ｒ）－１－（２，６－ジフルオロ－４－（（１－（３－フルオロプロピル）アゼチジン－３－イル）アミノ）フェニル）－３－メチル－１，３，４，９－テトラヒドロ－２Ｈ－ピリド［３，４－ｂ］インドール－２－イル）－２，２－ジフルオロプロパン－１－オールの固体形態及び置換されたフェニル又はピリジニル部分を含む縮合三環式化合物を調製するための方法とそれらの使用方法 | |
| JP2025176008A5 (https=) | ||
| CN105209437B (zh) | 心肌肌球蛋白激动剂的盐和制备盐的方法 | |
| KR101612642B1 (ko) | 테노포비어 알라펜아미드 헤미푸마레이트 | |
| TWI698428B (zh) | Mdm2抑制劑之製備方法及結晶型 | |
| JP2020059759A5 (https=) | ||
| JP2022523368A5 (https=) | ||
| JP2016106102A (ja) | （３ｒ，６ｒ）−３−（２，３−ジヒドロ−１ｈ−インデン−２−イル）−１−［（１ｒ）−１−（２，６−ジメチル−３−ピリジニル）−２−（４−モルホリニル）−２−オキソエチル］−６−［（１ｓ）−１−メチルプロピル］−２，５−ピペラジンジオンの新規結晶性形態 | |
| JP6830888B2 (ja) | Ｊａｋ阻害剤の硫酸水素塩の結晶形およびその製造方法 | |
| JP2018524308A (ja) | テノホビルアラフェナミドの共結晶、塩および結晶形態 | |
| JP2014074067A (ja) | メシル酸イマチニブのｆ、ｇ、ｈ、ｉおよびｋ結晶形 | |
| JP2022551525A5 (https=) | ||
| JP2006527758A (ja) | セロトニン及びノルアドレナリン再取り込み阻害薬としてのｎ−ピロリジン−３−イル−アミド誘導体 | |
| JP2024529533A5 (https=) | ||
| JP2022535850A5 (https=) | ||
| TWI374136B (en) | Water adduct of acetamide moohydrochloride and its crystal | |
| CN112119074A (zh) | Egfr抑制剂 | |
| JP2021503451A5 (https=) | ||
| JP2022553833A5 (https=) | ||
| JP2013544271A5 (https=) | ||
| JP2022540678A5 (https=) | ||
| WO2016151304A1 (en) | Novel polymorphic form x of nilotinib dihydrochloride hydrate | |
| JP2026509366A (ja) | Ｓｓｔｒ４アゴニスト及びその塩の調製のための方法 | |
| CN109937043A (zh) | N-(2-(2-(二甲基氨基)乙氧基)-4-甲氧基-5-((4-(1-甲基-1h-吲哚-3-基)嘧啶-2-基)氨基)苯基)丙烯酰胺的药物盐及其晶型 | |
| WO2000046201A1 (en) | Benzamide derivatives and drugs containing the same |